Gabriela Guillén Burrieza I am a pediatric surgeon, and since completing my specialist training I have subspecialized in the surgical treatment of pediatric and adolescent cancer. I am currently section head of the Oncological, Neonatal and Hepatobiliopancreatic Surgery unit of the Pediatric Surgery Department. My goal is to provide comprehensive care to our patients, which meets the highest quality standards, the incorporation of cutting edge technologies and the maximum scientific evidence, from a humanistic approach that puts the patient and their family at the center of care. Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca Head of Section Paediatric Oncological Surgery Children's Hospital and Woman's Hospital LinkedIn Twitter Orcid Email Gabriela Guillén Burrieza LinkedIn Twitter Orcid Email Institutions of which they are part Predoctoral researcher Childhood Cancer and Blood Disorders Vall Hebron Institut de Recerca Head of Section Paediatric Oncological Surgery Children's Hospital and Woman's Hospital I am a pediatric surgeon, and since completing my specialist training I have subspecialized in the surgical treatment of pediatric and adolescent cancer. I am currently section head of the Oncological, Neonatal and Hepatobiliopancreatic Surgery unit of the Pediatric Surgery Department. My goal is to provide comprehensive care to our patients, which meets the highest quality standards, the incorporation of cutting edge technologies and the maximum scientific evidence, from a humanistic approach that puts the patient and their family at the center of care.
Graduated in Medicine from the University of Salamanca, I did my specialty training in Pediatric Surgery at Vall d'Hebron Hospital. Since 2008 I have been part of the Pediatric Surgery department, first as an staff member and currently as head of section. Between 2008 and 2017 I was also tutor for doctors in training. My main area of specialization is pediatric surgical oncology, where I have focused most of my clinical practice and research projects, although other areas of my interest are neonatal, hepatobiliary and thoracic surgery. I have been a member of the European Pediatric Soft Tissue Sarcoma Study Group since 2012, first as part of the surgical subcommittee and since 2020, as part of the Board. In addition, I belong to and collaborate with other European pediatric cancer expert groups (SIOPEN, RTSG, EXPERT, SIOPEL), international (IPSO) and I am consultant for several national groups (SEHOP groups in soft tissue sarcomas, rare tumors and renal tumors ). Since 2024, I have been president of GRECOP (Spanish Group of Pediatric Surgical Oncology). In 2023, I presented my PhD at the Universitat Autònoma de Barcelona, titled "Development of Orthotopic PDX (Patient-Derived Xenografts) for Pediatric Extracranial Solid Tumors", focused on the generation of preclinical models in childhood cancer, achieving an excellent Cum Laude qualification. To date, I have published more than 70 scientific papers and book chapters, as an author or co-author, and I participate in several research projects both in pediatric cancer and in other areas of my specialty. I currently combine several research projects in pediatric cancer, as a member of the research group in Cancer and Children's Hematological Diseases of the VHIR, with more purely surgical projects (applications of intraoperative fluorescence, 3D reconstructions, development of minimally invasive techniques, projects of humanization in surgery, among others).
Projects Desarrollo avanzado de terapias innovadoras contra los sarcomas infantiles: refinamiento del bloqueo farmacológico de los co-receptores de la Vía Hedgehog IP: Josep Roma Castanyer Collaborators: Guillem Pons Barcons, Raquel Hladun Alvaro, Júlia Sansa Girona, Lia Garcia Gilabert, Gabriela Guillén Burrieza, Patricia Zarzosa Martinez Funding agency: Instituto de Salud Carlos III Funding: 190000 Reference: PI24/00825 Duration: 01/01/2025 - 31/12/2027 Incorporación de terapias dirigidas e inmunoterapia para el tratamiento de niños y adolescentes con neuroblastoma en recaída mediante su caracterización genómica y el desarrollo del ensayo clínico aleatorizado fase 2 BEACON2. IP: Lucas Moreno Martín-Retortillo Collaborators: Andrea Vilaplana Blanes, Aroa Soriano Fernández, Jessica Camacho Soriano, Lorena Valero Arrese, Raquel Hladun Alvaro, Gabriela Guillén Burrieza Funding agency: Instituto de Salud Carlos III Funding: 240000 Reference: PI24/01576 Duration: 01/01/2025 - 31/12/2027 TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas IP: Begoña Benito Villabriga Collaborators: Carmen Escudero Iriarte, Laia Ventura i Expósito, Susana Otero Romero, Ignacio Ferreira González, José Antonio Barrabés Riu, Carlos Nos Llopis, Pablo Velasco Puyó, Jose Fernando Rodríguez Palomares, Belen Perez Dueñas, Jaume Sastre Garriga, Joan López Hellin, Antonia Sambola Ayala, Jordi Rio Izquierdo, Nuria Rivas Gandara, Jordi Perez Rodon, Aroa Soriano Fernández, Manuel Comabella Lopez, Antonio Rodríguez Sinovas, Gisela Teixido i Tura, Antonia Pijuan Domenech, Roser Ferrer Costa, Carmen Tur Gomez, Maria Cristina Díaz de Heredia Rubio, Laia Yañez Bisbe, Maria Jose Pérez García, Miguel Segura Ginard, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Cristina Auger Acosta, Neus Bellera Gotarda, TACTIC: Explorando soluciones a los retos de salud mediante ciencia disruptiva, terapias avanzadas y medicina de sistemas, Herena Eixarch Ahufinger, M Mar Mañu Pereira, Deborah Pareto Onghena, Lorena Valero Arrese, Aitor Uribarri Gonzalez, Jordi Bañeras Rius, Alex Rovira Cañellas, Mar Tintore Subirana, Bruno Garcia del Blanco, Ana Vivancos Prellezo, Maria Teresa Salcedo Allende, Marisol Ruiz Meana, Ana Belén Méndez Fernández, Anna Llort Sales, Carmen Espejo Ruiz, Raquel Hladun Alvaro, Sandra Mancilla Zamora, Ana Zabalza de Torres, Marc Miquel Moltó Abad, Javier Inserte Igual, Luciana Midaglia Fernandez, Gabriela Guillén Burrieza, David Gómez Andrés, Alvaro Cobo Calvo, Alvaro Calabuig Goena, Joaquin Castillo Justribo, Lucas Moreno Martín-Retortillo, Andres Miguez Gonzalez, Josep Roma Castanyer, Laura Dos Subirá, Jaume Capdevila Castillon, Nicolás Miguel Fissolo , Maria Nazarena Pizzi, Paolo Giovanni Nuciforo, Tian Tian, Andrea Guala , Juan Pablo Betancur Rengifo Funding agency: Instituto de Salud Carlos III Funding: 2494527.53 Reference: FORT23/00034 Duration: 01/01/2024 - 31/12/2027 Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders IP: Lucas Moreno Martín-Retortillo Collaborators: Luís Gros Subias, Raquel Andreu Vilarroig, Andrea Vilaplana Blanes, Pablo Velasco Puyó, Laura Murillo Sanjuán, Maria Isabel Benitez Carabante, Aroa Soriano Fernández, Guillem Pons Barcons, Jose Miguel Lizcano De Vega, Maria Cristina Díaz de Heredia Rubio, Maria Luz Uría Oficialdegui, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Miguel Segura Ginard, M Mar Mañu Pereira, Lorena Valero Arrese, Thaïs Murciano Carrillo, Constantino Sábado Álvarez, Anna Llort Sales, Raquel Hladun Alvaro, Carlota Aguilera Ordoñez, Adria Molero Valenzuela, Grup de Recerca Emergent (GRE) Childood Cancer & Blood disorders, Gabriela Guillén Burrieza, Laura Alonso Garcia, Idoia Bolinaga Ayala, Josep Roma Castanyer, Sergio Espinosa Gil, Elena Andretta, Claire Diot, Amira Idrizovic Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 00638 Duration: 01/01/2022 - 30/06/2025 Pagination Current page 1 Page 2 Page 3 Next page › Last page »
